Targeting the development and effector functions of TH17 cells

被引:79
作者
Ghilardi, Nico [1 ]
Ouyang, Wenjun [2 ]
机构
[1] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
关键词
TH17; interleukin-17; interleukin-6; interleukin-23; autoimmune disease;
D O I
10.1016/j.smim.2007.10.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T helper (TH) cells can assume different phenotypes characterized by the secretion of distinct effector molecules. Interferon-gamma producing TH1 and IL-4 producing TH2 cells have long been recognized as important mediators of host defense, whereas regulatory T cells are known to suppress T cell responses. Recently, TH17 cells were characterized as a novel CD4(+) subset that preferentially produces IL-17, IL-17F, and IL-22 as the signature cytokines. TH17 cells appear to play a critical role in sustaining the inflammatory response and their presence is closely associated with autoimmune disease, which makes them an attractive therapeutic target. In this review, we focus on the mechanisms that regulate the differentiation of naive T cells into TH17 cells and on TH17 effector cytokines, as they represent opportunities for therapeutic intervention. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:383 / 393
页数:11
相关论文
共 121 条
  • [31] Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO
  • [32] 2-D
  • [33] Inborn errors of IL-12/23- and IFN-γ-mediated immunity:: molecular, cellular, and clinical features
    Filipe-Santos, Orchidee
    Bustamante, Jacinta
    Chapgier, Ariane
    Vogt, Guillaume
    de Beaucoudrey, Ludovic
    Feinberg, Jacqueline
    Jouanguy, Emmanuelle
    Boisson-Dupuis, Stephanie
    Fieschi, Claire
    Picard, Capucine
    Casanova, Jean-Laurent
    [J]. SEMINARS IN IMMUNOLOGY, 2006, 18 (06) : 347 - 361
  • [34] FINBLOOM DS, 1995, J IMMUNOL, V155, P1079
  • [35] IL-25 induces IL-4 IL-5, and IL-13 and Th2-associated pathologies in vivo
    Fort, MM
    Cheung, J
    Yen, D
    Li, J
    Zurawski, SM
    Lo, S
    Menon, S
    Clifford, T
    Hunte, B
    Lesley, R
    Muchamuel, T
    Hurst, SD
    Zurawski, G
    Leach, MW
    Gorman, DM
    Rennick, DM
    [J]. IMMUNITY, 2001, 15 (06) : 985 - 995
  • [36] Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
    Fuss, IJ
    Becker, C
    Yang, ZQ
    Groden, C
    Hornung, RL
    Heller, F
    Neurath, MF
    Strober, W
    Mannon, PJ
    [J]. INFLAMMATORY BOWEL DISEASES, 2006, 12 (01) : 9 - 15
  • [37] Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice
    Ghilardi, N
    Kljavin, N
    Chen, Q
    Lucas, S
    Gurney, AL
    de Sauvage, FJ
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (05) : 2827 - 2833
  • [38] Transforming growth factor-β in T-cell biology
    Gorelik, L
    Flavell, RA
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (01) : 46 - 53
  • [39] Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae
    Happel, KI
    Dubin, PJ
    Zheng, MQ
    Ghilardi, N
    Lockhart, C
    Quinton, LJ
    Odden, AR
    Shellito, JE
    Bagby, GJ
    Nelson, S
    Kolls, JK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (06) : 761 - 769
  • [40] Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
    Harrington, LE
    Hatton, RD
    Mangan, PR
    Turner, H
    Murphy, TL
    Murphy, KM
    Weaver, CT
    [J]. NATURE IMMUNOLOGY, 2005, 6 (11) : 1123 - 1132